nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2C9—Gefitinib—lung cancer	0.0301	0.0733	CbGbCtD
Mirtazapine—CYP2C9—Teniposide—lung cancer	0.0292	0.071	CbGbCtD
Mirtazapine—CYP2D6—Gefitinib—lung cancer	0.0275	0.067	CbGbCtD
Mirtazapine—CYP2C8—Erlotinib—lung cancer	0.0255	0.0621	CbGbCtD
Mirtazapine—CYP2C8—Paclitaxel—lung cancer	0.0234	0.0568	CbGbCtD
Mirtazapine—CYP2D6—Vinorelbine—lung cancer	0.0212	0.0516	CbGbCtD
Mirtazapine—CYP1A2—Erlotinib—lung cancer	0.0197	0.0481	CbGbCtD
Mirtazapine—CYP3A4—Topotecan—lung cancer	0.0191	0.0466	CbGbCtD
Mirtazapine—CYP2C8—Etoposide—lung cancer	0.0185	0.0449	CbGbCtD
Mirtazapine—CYP3A4—Gefitinib—lung cancer	0.0175	0.0426	CbGbCtD
Mirtazapine—CYP3A4—Teniposide—lung cancer	0.017	0.0413	CbGbCtD
Mirtazapine—CYP2C9—Paclitaxel—lung cancer	0.0163	0.0396	CbGbCtD
Mirtazapine—CYP2D6—Erlotinib—lung cancer	0.0163	0.0396	CbGbCtD
Mirtazapine—CYP1A2—Etoposide—lung cancer	0.0143	0.0348	CbGbCtD
Mirtazapine—CYP3A4—Vinorelbine—lung cancer	0.0135	0.0328	CbGbCtD
Mirtazapine—CYP2C9—Cisplatin—lung cancer	0.0131	0.0319	CbGbCtD
Mirtazapine—CYP2D6—Vinblastine—lung cancer	0.0131	0.0318	CbGbCtD
Mirtazapine—CYP3A4—Crizotinib—lung cancer	0.0107	0.0261	CbGbCtD
Mirtazapine—HTR2A—phrenic nerve—lung cancer	0.0105	0.203	CbGeAlD
Mirtazapine—CYP3A4—Erlotinib—lung cancer	0.0103	0.0252	CbGbCtD
Mirtazapine—CYP3A4—Paclitaxel—lung cancer	0.00947	0.0231	CbGbCtD
Mirtazapine—CYP3A4—Irinotecan—lung cancer	0.00934	0.0227	CbGbCtD
Mirtazapine—CYP3A4—Vinblastine—lung cancer	0.00831	0.0202	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—lung cancer	0.00803	0.0195	CbGbCtD
Mirtazapine—CYP3A4—Etoposide—lung cancer	0.00748	0.0182	CbGbCtD
Mirtazapine—CYP3A4—Docetaxel—lung cancer	0.00685	0.0167	CbGbCtD
Mirtazapine—HTR7—pulmonary artery—lung cancer	0.00611	0.118	CbGeAlD
Mirtazapine—CYP3A4—Doxorubicin—lung cancer	0.0051	0.0124	CbGbCtD
Mirtazapine—HTR2A—pulmonary artery—lung cancer	0.00381	0.0738	CbGeAlD
Mirtazapine—HTR3A—respiratory system—lung cancer	0.00159	0.0308	CbGeAlD
Mirtazapine—SLC6A3—respiratory system—lung cancer	0.00132	0.0256	CbGeAlD
Mirtazapine—CYP2C8—mammary gland—lung cancer	0.00131	0.0255	CbGeAlD
Mirtazapine—SLC6A4—respiratory system—lung cancer	0.00121	0.0235	CbGeAlD
Mirtazapine—CYP2C9—mammary gland—lung cancer	0.00117	0.0226	CbGeAlD
Mirtazapine—SLC6A2—respiratory system—lung cancer	0.00107	0.0207	CbGeAlD
Mirtazapine—ADRB1—bronchus—lung cancer	0.00103	0.02	CbGeAlD
Mirtazapine—HTR7—respiratory system—lung cancer	0.00103	0.0199	CbGeAlD
Mirtazapine—DRD2—respiratory system—lung cancer	0.000972	0.0188	CbGeAlD
Mirtazapine—ADRB1—cardiac atrium—lung cancer	0.00087	0.0169	CbGeAlD
Mirtazapine—HTR7—epithelium—lung cancer	0.000859	0.0166	CbGeAlD
Mirtazapine—HTR3A—lung—lung cancer	0.000843	0.0163	CbGeAlD
Mirtazapine—ADRA1A—epithelium—lung cancer	0.000828	0.016	CbGeAlD
Mirtazapine—CYP1A2—respiratory system—lung cancer	0.00082	0.0159	CbGeAlD
Mirtazapine—ADRA2C—bronchus—lung cancer	0.000777	0.0151	CbGeAlD
Mirtazapine—HRH1—respiratory system—lung cancer	0.000767	0.0149	CbGeAlD
Mirtazapine—HTR7—trachea—lung cancer	0.000759	0.0147	CbGeAlD
Mirtazapine—SLC6A3—lung—lung cancer	0.000702	0.0136	CbGeAlD
Mirtazapine—ADRA2C—trachea—lung cancer	0.000698	0.0135	CbGeAlD
Mirtazapine—ADRB1—lung—lung cancer	0.000666	0.0129	CbGeAlD
Mirtazapine—ADRA2C—cardiac atrium—lung cancer	0.000656	0.0127	CbGeAlD
Mirtazapine—SLC6A4—lung—lung cancer	0.000643	0.0125	CbGeAlD
Mirtazapine—HRH1—epithelium—lung cancer	0.000641	0.0124	CbGeAlD
Mirtazapine—HTR2A—respiratory system—lung cancer	0.000641	0.0124	CbGeAlD
Mirtazapine—HTR2B—lung—lung cancer	0.000637	0.0123	CbGeAlD
Mirtazapine—ADRA2A—bronchus—lung cancer	0.00062	0.012	CbGeAlD
Mirtazapine—HRH1—trachea—lung cancer	0.000567	0.011	CbGeAlD
Mirtazapine—SLC6A2—lung—lung cancer	0.000566	0.011	CbGeAlD
Mirtazapine—ADRA2A—trachea—lung cancer	0.000557	0.0108	CbGeAlD
Mirtazapine—HTR7—lung—lung cancer	0.000546	0.0106	CbGeAlD
Mirtazapine—HTR2A—epithelium—lung cancer	0.000536	0.0104	CbGeAlD
Mirtazapine—ADRA2A—cardiac atrium—lung cancer	0.000523	0.0101	CbGeAlD
Mirtazapine—DRD2—lung—lung cancer	0.000516	0.00999	CbGeAlD
Mirtazapine—ADRA2C—lung—lung cancer	0.000502	0.00971	CbGeAlD
Mirtazapine—HTR2A—trachea—lung cancer	0.000474	0.00917	CbGeAlD
Mirtazapine—HTR2B—lymph node—lung cancer	0.000436	0.00844	CbGeAlD
Mirtazapine—CYP1A2—lung—lung cancer	0.000435	0.00843	CbGeAlD
Mirtazapine—HRH1—lung—lung cancer	0.000407	0.00789	CbGeAlD
Mirtazapine—ADRA2A—lung—lung cancer	0.0004	0.00775	CbGeAlD
Mirtazapine—SLC6A2—lymph node—lung cancer	0.000387	0.0075	CbGeAlD
Mirtazapine—ADRA2C—lymph node—lung cancer	0.000343	0.00664	CbGeAlD
Mirtazapine—HTR2A—lung—lung cancer	0.00034	0.00659	CbGeAlD
Mirtazapine—HRH1—lymph node—lung cancer	0.000279	0.0054	CbGeAlD
Mirtazapine—ADRA2A—lymph node—lung cancer	0.000274	0.0053	CbGeAlD
Mirtazapine—Neutropenia—Doxorubicin—lung cancer	0.000106	0.000301	CcSEcCtD
Mirtazapine—Decreased appetite—Paclitaxel—lung cancer	0.000106	0.000301	CcSEcCtD
Mirtazapine—Dry mouth—Docetaxel—lung cancer	0.000105	0.000299	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000105	0.000299	CcSEcCtD
Mirtazapine—Fatigue—Paclitaxel—lung cancer	0.000105	0.000298	CcSEcCtD
Mirtazapine—Hepatitis—Methotrexate—lung cancer	0.000105	0.000297	CcSEcCtD
Mirtazapine—Pollakiuria—Doxorubicin—lung cancer	0.000105	0.000297	CcSEcCtD
Mirtazapine—Asthenia—Gemcitabine—lung cancer	0.000104	0.000296	CcSEcCtD
Mirtazapine—Constipation—Paclitaxel—lung cancer	0.000104	0.000296	CcSEcCtD
Mirtazapine—Pain—Paclitaxel—lung cancer	0.000104	0.000296	CcSEcCtD
Mirtazapine—Confusional state—Docetaxel—lung cancer	0.000104	0.000296	CcSEcCtD
Mirtazapine—Pharyngitis—Methotrexate—lung cancer	0.000104	0.000295	CcSEcCtD
Mirtazapine—Urinary tract disorder—Methotrexate—lung cancer	0.000103	0.000294	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000103	0.000294	CcSEcCtD
Mirtazapine—Oedema—Docetaxel—lung cancer	0.000103	0.000293	CcSEcCtD
Mirtazapine—Weight increased—Doxorubicin—lung cancer	0.000103	0.000293	CcSEcCtD
Mirtazapine—Pruritus—Gemcitabine—lung cancer	0.000103	0.000292	CcSEcCtD
Mirtazapine—Urethral disorder—Methotrexate—lung cancer	0.000103	0.000292	CcSEcCtD
Mirtazapine—Infection—Docetaxel—lung cancer	0.000103	0.000291	CcSEcCtD
Mirtazapine—Weight decreased—Doxorubicin—lung cancer	0.000102	0.000291	CcSEcCtD
Mirtazapine—Feeling abnormal—Etoposide—lung cancer	0.000102	0.000291	CcSEcCtD
Mirtazapine—Diarrhoea—Irinotecan—lung cancer	0.000102	0.00029	CcSEcCtD
Mirtazapine—Pneumonia—Doxorubicin—lung cancer	0.000102	0.000289	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Etoposide—lung cancer	0.000102	0.000288	CcSEcCtD
Mirtazapine—Shock—Docetaxel—lung cancer	0.000102	0.000288	CcSEcCtD
Mirtazapine—Nervous system disorder—Docetaxel—lung cancer	0.000101	0.000287	CcSEcCtD
Mirtazapine—Thrombocytopenia—Docetaxel—lung cancer	0.000101	0.000287	CcSEcCtD
Mirtazapine—Drowsiness—Doxorubicin—lung cancer	0.000101	0.000287	CcSEcCtD
Mirtazapine—Tachycardia—Docetaxel—lung cancer	0.000101	0.000286	CcSEcCtD
Mirtazapine—Feeling abnormal—Paclitaxel—lung cancer	0.0001	0.000285	CcSEcCtD
Mirtazapine—Skin disorder—Docetaxel—lung cancer	0.0001	0.000285	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.0001	0.000284	CcSEcCtD
Mirtazapine—Hypersensitivity—Cisplatin—lung cancer	9.99e-05	0.000284	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Paclitaxel—lung cancer	9.96e-05	0.000283	CcSEcCtD
Mirtazapine—Diarrhoea—Gemcitabine—lung cancer	9.95e-05	0.000283	CcSEcCtD
Mirtazapine—Erythema multiforme—Methotrexate—lung cancer	9.9e-05	0.000281	CcSEcCtD
Mirtazapine—Dizziness—Irinotecan—lung cancer	9.87e-05	0.00028	CcSEcCtD
Mirtazapine—Urticaria—Etoposide—lung cancer	9.86e-05	0.00028	CcSEcCtD
Mirtazapine—Jaundice—Doxorubicin—lung cancer	9.84e-05	0.00028	CcSEcCtD
Mirtazapine—Stomatitis—Doxorubicin—lung cancer	9.84e-05	0.00028	CcSEcCtD
Mirtazapine—Anorexia—Docetaxel—lung cancer	9.84e-05	0.000279	CcSEcCtD
Mirtazapine—Body temperature increased—Etoposide—lung cancer	9.82e-05	0.000279	CcSEcCtD
Mirtazapine—Abdominal pain—Etoposide—lung cancer	9.82e-05	0.000279	CcSEcCtD
Mirtazapine—Urinary tract infection—Doxorubicin—lung cancer	9.82e-05	0.000279	CcSEcCtD
Mirtazapine—Conjunctivitis—Doxorubicin—lung cancer	9.82e-05	0.000279	CcSEcCtD
Mirtazapine—Eye disorder—Methotrexate—lung cancer	9.78e-05	0.000278	CcSEcCtD
Mirtazapine—Tinnitus—Methotrexate—lung cancer	9.76e-05	0.000277	CcSEcCtD
Mirtazapine—Asthenia—Cisplatin—lung cancer	9.73e-05	0.000276	CcSEcCtD
Mirtazapine—Cardiac disorder—Methotrexate—lung cancer	9.72e-05	0.000276	CcSEcCtD
Mirtazapine—Sweating—Doxorubicin—lung cancer	9.68e-05	0.000275	CcSEcCtD
Mirtazapine—Urticaria—Paclitaxel—lung cancer	9.67e-05	0.000275	CcSEcCtD
Mirtazapine—Hypotension—Docetaxel—lung cancer	9.64e-05	0.000274	CcSEcCtD
Mirtazapine—Haematuria—Doxorubicin—lung cancer	9.63e-05	0.000274	CcSEcCtD
Mirtazapine—Abdominal pain—Paclitaxel—lung cancer	9.62e-05	0.000273	CcSEcCtD
Mirtazapine—Body temperature increased—Paclitaxel—lung cancer	9.62e-05	0.000273	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Doxorubicin—lung cancer	9.55e-05	0.000271	CcSEcCtD
Mirtazapine—Epistaxis—Doxorubicin—lung cancer	9.53e-05	0.000271	CcSEcCtD
Mirtazapine—Angiopathy—Methotrexate—lung cancer	9.5e-05	0.00027	CcSEcCtD
Mirtazapine—Vomiting—Irinotecan—lung cancer	9.49e-05	0.00027	CcSEcCtD
Mirtazapine—Sinusitis—Doxorubicin—lung cancer	9.47e-05	0.000269	CcSEcCtD
Mirtazapine—Agranulocytosis—Doxorubicin—lung cancer	9.42e-05	0.000268	CcSEcCtD
Mirtazapine—Rash—Irinotecan—lung cancer	9.41e-05	0.000267	CcSEcCtD
Mirtazapine—Dermatitis—Irinotecan—lung cancer	9.4e-05	0.000267	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Docetaxel—lung cancer	9.4e-05	0.000267	CcSEcCtD
Mirtazapine—Chills—Methotrexate—lung cancer	9.39e-05	0.000267	CcSEcCtD
Mirtazapine—Headache—Irinotecan—lung cancer	9.35e-05	0.000266	CcSEcCtD
Mirtazapine—Insomnia—Docetaxel—lung cancer	9.33e-05	0.000265	CcSEcCtD
Mirtazapine—Diarrhoea—Cisplatin—lung cancer	9.27e-05	0.000263	CcSEcCtD
Mirtazapine—Paraesthesia—Docetaxel—lung cancer	9.27e-05	0.000263	CcSEcCtD
Mirtazapine—Alopecia—Methotrexate—lung cancer	9.25e-05	0.000263	CcSEcCtD
Mirtazapine—Vomiting—Gemcitabine—lung cancer	9.25e-05	0.000263	CcSEcCtD
Mirtazapine—Bradycardia—Doxorubicin—lung cancer	9.23e-05	0.000262	CcSEcCtD
Mirtazapine—Dyspnoea—Docetaxel—lung cancer	9.2e-05	0.000261	CcSEcCtD
Mirtazapine—Somnolence—Docetaxel—lung cancer	9.17e-05	0.000261	CcSEcCtD
Mirtazapine—Mental disorder—Methotrexate—lung cancer	9.17e-05	0.000261	CcSEcCtD
Mirtazapine—Rash—Gemcitabine—lung cancer	9.17e-05	0.00026	CcSEcCtD
Mirtazapine—Dermatitis—Gemcitabine—lung cancer	9.16e-05	0.00026	CcSEcCtD
Mirtazapine—Hypersensitivity—Etoposide—lung cancer	9.15e-05	0.00026	CcSEcCtD
Mirtazapine—Malnutrition—Methotrexate—lung cancer	9.11e-05	0.000259	CcSEcCtD
Mirtazapine—Headache—Gemcitabine—lung cancer	9.11e-05	0.000259	CcSEcCtD
Mirtazapine—Rhinitis—Doxorubicin—lung cancer	9.09e-05	0.000258	CcSEcCtD
Mirtazapine—Dyspepsia—Docetaxel—lung cancer	9.08e-05	0.000258	CcSEcCtD
Mirtazapine—Hepatitis—Doxorubicin—lung cancer	9.07e-05	0.000258	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—lung cancer	9.02e-05	0.000256	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—lung cancer	9e-05	0.000256	CcSEcCtD
Mirtazapine—Decreased appetite—Docetaxel—lung cancer	8.97e-05	0.000255	CcSEcCtD
Mirtazapine—Hypersensitivity—Paclitaxel—lung cancer	8.97e-05	0.000255	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—lung cancer	8.95e-05	0.000254	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—lung cancer	8.93e-05	0.000254	CcSEcCtD
Mirtazapine—Dysgeusia—Methotrexate—lung cancer	8.92e-05	0.000254	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Docetaxel—lung cancer	8.91e-05	0.000253	CcSEcCtD
Mirtazapine—Asthenia—Etoposide—lung cancer	8.91e-05	0.000253	CcSEcCtD
Mirtazapine—Fatigue—Docetaxel—lung cancer	8.9e-05	0.000253	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—lung cancer	8.89e-05	0.000252	CcSEcCtD
Mirtazapine—Nausea—Irinotecan—lung cancer	8.87e-05	0.000252	CcSEcCtD
Mirtazapine—Pain—Docetaxel—lung cancer	8.83e-05	0.000251	CcSEcCtD
Mirtazapine—Constipation—Docetaxel—lung cancer	8.83e-05	0.000251	CcSEcCtD
Mirtazapine—Back pain—Methotrexate—lung cancer	8.82e-05	0.00025	CcSEcCtD
Mirtazapine—Pruritus—Etoposide—lung cancer	8.79e-05	0.00025	CcSEcCtD
Mirtazapine—Asthenia—Paclitaxel—lung cancer	8.74e-05	0.000248	CcSEcCtD
Mirtazapine—Nausea—Gemcitabine—lung cancer	8.64e-05	0.000245	CcSEcCtD
Mirtazapine—Vomiting—Cisplatin—lung cancer	8.62e-05	0.000245	CcSEcCtD
Mirtazapine—Pruritus—Paclitaxel—lung cancer	8.61e-05	0.000245	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—lung cancer	8.57e-05	0.000243	CcSEcCtD
Mirtazapine—Rash—Cisplatin—lung cancer	8.55e-05	0.000243	CcSEcCtD
Mirtazapine—Dermatitis—Cisplatin—lung cancer	8.54e-05	0.000243	CcSEcCtD
Mirtazapine—Feeling abnormal—Docetaxel—lung cancer	8.5e-05	0.000242	CcSEcCtD
Mirtazapine—Diarrhoea—Etoposide—lung cancer	8.5e-05	0.000241	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—lung cancer	8.47e-05	0.000241	CcSEcCtD
Mirtazapine—Ill-defined disorder—Methotrexate—lung cancer	8.46e-05	0.00024	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—lung cancer	8.45e-05	0.00024	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Docetaxel—lung cancer	8.44e-05	0.00024	CcSEcCtD
Mirtazapine—Anaemia—Methotrexate—lung cancer	8.42e-05	0.000239	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—lung cancer	8.41e-05	0.000239	CcSEcCtD
Mirtazapine—Diarrhoea—Paclitaxel—lung cancer	8.33e-05	0.000237	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—lung cancer	8.22e-05	0.000234	CcSEcCtD
Mirtazapine—Malaise—Methotrexate—lung cancer	8.22e-05	0.000233	CcSEcCtD
Mirtazapine—Dizziness—Etoposide—lung cancer	8.21e-05	0.000233	CcSEcCtD
Mirtazapine—Vertigo—Methotrexate—lung cancer	8.19e-05	0.000233	CcSEcCtD
Mirtazapine—Abdominal pain—Docetaxel—lung cancer	8.16e-05	0.000232	CcSEcCtD
Mirtazapine—Body temperature increased—Docetaxel—lung cancer	8.16e-05	0.000232	CcSEcCtD
Mirtazapine—Leukopenia—Methotrexate—lung cancer	8.16e-05	0.000232	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—lung cancer	8.13e-05	0.000231	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—lung cancer	8.1e-05	0.00023	CcSEcCtD
Mirtazapine—Dizziness—Paclitaxel—lung cancer	8.05e-05	0.000229	CcSEcCtD
Mirtazapine—Nausea—Cisplatin—lung cancer	8.05e-05	0.000229	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—lung cancer	8.01e-05	0.000228	CcSEcCtD
Mirtazapine—Cough—Methotrexate—lung cancer	7.95e-05	0.000226	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—lung cancer	7.94e-05	0.000226	CcSEcCtD
Mirtazapine—Convulsion—Methotrexate—lung cancer	7.9e-05	0.000224	CcSEcCtD
Mirtazapine—Vomiting—Etoposide—lung cancer	7.9e-05	0.000224	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—lung cancer	7.89e-05	0.000224	CcSEcCtD
Mirtazapine—Rash—Etoposide—lung cancer	7.83e-05	0.000222	CcSEcCtD
Mirtazapine—Dermatitis—Etoposide—lung cancer	7.82e-05	0.000222	CcSEcCtD
Mirtazapine—Headache—Etoposide—lung cancer	7.78e-05	0.000221	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—lung cancer	7.78e-05	0.000221	CcSEcCtD
Mirtazapine—Arthralgia—Methotrexate—lung cancer	7.76e-05	0.00022	CcSEcCtD
Mirtazapine—Chest pain—Methotrexate—lung cancer	7.76e-05	0.00022	CcSEcCtD
Mirtazapine—Myalgia—Methotrexate—lung cancer	7.76e-05	0.00022	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—lung cancer	7.74e-05	0.00022	CcSEcCtD
Mirtazapine—Vomiting—Paclitaxel—lung cancer	7.74e-05	0.00022	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—lung cancer	7.73e-05	0.00022	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.71e-05	0.000219	CcSEcCtD
Mirtazapine—Rash—Paclitaxel—lung cancer	7.68e-05	0.000218	CcSEcCtD
Mirtazapine—Dermatitis—Paclitaxel—lung cancer	7.67e-05	0.000218	CcSEcCtD
Mirtazapine—Discomfort—Methotrexate—lung cancer	7.67e-05	0.000218	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—lung cancer	7.66e-05	0.000218	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—lung cancer	7.63e-05	0.000217	CcSEcCtD
Mirtazapine—Headache—Paclitaxel—lung cancer	7.63e-05	0.000217	CcSEcCtD
Mirtazapine—Hypersensitivity—Docetaxel—lung cancer	7.6e-05	0.000216	CcSEcCtD
Mirtazapine—Confusional state—Methotrexate—lung cancer	7.5e-05	0.000213	CcSEcCtD
Mirtazapine—Asthenia—Docetaxel—lung cancer	7.4e-05	0.00021	CcSEcCtD
Mirtazapine—Infection—Methotrexate—lung cancer	7.39e-05	0.00021	CcSEcCtD
Mirtazapine—Nausea—Etoposide—lung cancer	7.38e-05	0.00021	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—lung cancer	7.32e-05	0.000208	CcSEcCtD
Mirtazapine—Pruritus—Docetaxel—lung cancer	7.3e-05	0.000207	CcSEcCtD
Mirtazapine—Nervous system disorder—Methotrexate—lung cancer	7.29e-05	0.000207	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—lung cancer	7.29e-05	0.000207	CcSEcCtD
Mirtazapine—Thrombocytopenia—Methotrexate—lung cancer	7.28e-05	0.000207	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—lung cancer	7.25e-05	0.000206	CcSEcCtD
Mirtazapine—Nausea—Paclitaxel—lung cancer	7.23e-05	0.000205	CcSEcCtD
Mirtazapine—Skin disorder—Methotrexate—lung cancer	7.22e-05	0.000205	CcSEcCtD
Mirtazapine—Hyperhidrosis—Methotrexate—lung cancer	7.19e-05	0.000204	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—lung cancer	7.12e-05	0.000202	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—lung cancer	7.09e-05	0.000201	CcSEcCtD
Mirtazapine—Anorexia—Methotrexate—lung cancer	7.09e-05	0.000201	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—lung cancer	7.08e-05	0.000201	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—lung cancer	7.06e-05	0.000201	CcSEcCtD
Mirtazapine—Diarrhoea—Docetaxel—lung cancer	7.06e-05	0.000201	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—lung cancer	6.97e-05	0.000198	CcSEcCtD
Mirtazapine—Hypotension—Methotrexate—lung cancer	6.95e-05	0.000197	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—lung cancer	6.94e-05	0.000197	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—lung cancer	6.89e-05	0.000196	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—lung cancer	6.84e-05	0.000194	CcSEcCtD
Mirtazapine—Dizziness—Docetaxel—lung cancer	6.82e-05	0.000194	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—lung cancer	6.81e-05	0.000194	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Methotrexate—lung cancer	6.78e-05	0.000192	CcSEcCtD
Mirtazapine—Insomnia—Methotrexate—lung cancer	6.73e-05	0.000191	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—lung cancer	6.72e-05	0.000191	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—lung cancer	6.72e-05	0.000191	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—lung cancer	6.72e-05	0.000191	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—lung cancer	6.7e-05	0.00019	CcSEcCtD
Mirtazapine—Paraesthesia—Methotrexate—lung cancer	6.68e-05	0.00019	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.67e-05	0.00019	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—lung cancer	6.64e-05	0.000189	CcSEcCtD
Mirtazapine—Dyspnoea—Methotrexate—lung cancer	6.63e-05	0.000188	CcSEcCtD
Mirtazapine—Somnolence—Methotrexate—lung cancer	6.61e-05	0.000188	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—lung cancer	6.57e-05	0.000187	CcSEcCtD
Mirtazapine—Vomiting—Docetaxel—lung cancer	6.56e-05	0.000186	CcSEcCtD
Mirtazapine—Dyspepsia—Methotrexate—lung cancer	6.55e-05	0.000186	CcSEcCtD
Mirtazapine—Rash—Docetaxel—lung cancer	6.51e-05	0.000185	CcSEcCtD
Mirtazapine—Dermatitis—Docetaxel—lung cancer	6.5e-05	0.000185	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—lung cancer	6.49e-05	0.000184	CcSEcCtD
Mirtazapine—Decreased appetite—Methotrexate—lung cancer	6.47e-05	0.000184	CcSEcCtD
Mirtazapine—Headache—Docetaxel—lung cancer	6.47e-05	0.000184	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—lung cancer	6.44e-05	0.000183	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Methotrexate—lung cancer	6.42e-05	0.000182	CcSEcCtD
Mirtazapine—Fatigue—Methotrexate—lung cancer	6.41e-05	0.000182	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—lung cancer	6.4e-05	0.000182	CcSEcCtD
Mirtazapine—Pain—Methotrexate—lung cancer	6.36e-05	0.000181	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—lung cancer	6.34e-05	0.00018	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—lung cancer	6.32e-05	0.000179	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—lung cancer	6.31e-05	0.000179	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—lung cancer	6.29e-05	0.000179	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—lung cancer	6.26e-05	0.000178	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—lung cancer	6.23e-05	0.000177	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—lung cancer	6.14e-05	0.000174	CcSEcCtD
Mirtazapine—Nausea—Docetaxel—lung cancer	6.13e-05	0.000174	CcSEcCtD
Mirtazapine—Feeling abnormal—Methotrexate—lung cancer	6.13e-05	0.000174	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Methotrexate—lung cancer	6.08e-05	0.000173	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—lung cancer	6.02e-05	0.000171	CcSEcCtD
Mirtazapine—Urticaria—Methotrexate—lung cancer	5.91e-05	0.000168	CcSEcCtD
Mirtazapine—Abdominal pain—Methotrexate—lung cancer	5.88e-05	0.000167	CcSEcCtD
Mirtazapine—Body temperature increased—Methotrexate—lung cancer	5.88e-05	0.000167	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.87e-05	0.000167	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—lung cancer	5.83e-05	0.000165	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—lung cancer	5.78e-05	0.000164	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—lung cancer	5.74e-05	0.000163	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—lung cancer	5.73e-05	0.000163	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—lung cancer	5.67e-05	0.000161	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—lung cancer	5.6e-05	0.000159	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—lung cancer	5.56e-05	0.000158	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—lung cancer	5.55e-05	0.000158	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—lung cancer	5.51e-05	0.000156	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—lung cancer	5.51e-05	0.000156	CcSEcCtD
Mirtazapine—Hypersensitivity—Methotrexate—lung cancer	5.48e-05	0.000156	CcSEcCtD
Mirtazapine—Asthenia—Methotrexate—lung cancer	5.34e-05	0.000152	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—lung cancer	5.31e-05	0.000151	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—lung cancer	5.27e-05	0.00015	CcSEcCtD
Mirtazapine—Pruritus—Methotrexate—lung cancer	5.26e-05	0.000149	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—lung cancer	5.12e-05	0.000145	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—lung cancer	5.09e-05	0.000145	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—lung cancer	5.09e-05	0.000145	CcSEcCtD
Mirtazapine—Diarrhoea—Methotrexate—lung cancer	5.09e-05	0.000145	CcSEcCtD
Mirtazapine—Dizziness—Methotrexate—lung cancer	4.92e-05	0.00014	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—lung cancer	4.75e-05	0.000135	CcSEcCtD
Mirtazapine—Vomiting—Methotrexate—lung cancer	4.73e-05	0.000134	CcSEcCtD
Mirtazapine—Rash—Methotrexate—lung cancer	4.69e-05	0.000133	CcSEcCtD
Mirtazapine—Dermatitis—Methotrexate—lung cancer	4.69e-05	0.000133	CcSEcCtD
Mirtazapine—Headache—Methotrexate—lung cancer	4.66e-05	0.000132	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—lung cancer	4.62e-05	0.000131	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—lung cancer	4.56e-05	0.000129	CcSEcCtD
Mirtazapine—Nausea—Methotrexate—lung cancer	4.42e-05	0.000125	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—lung cancer	4.41e-05	0.000125	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—lung cancer	4.26e-05	0.000121	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—lung cancer	4.1e-05	0.000116	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—lung cancer	4.06e-05	0.000115	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—lung cancer	4.06e-05	0.000115	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—lung cancer	4.03e-05	0.000115	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—lung cancer	3.83e-05	0.000109	CcSEcCtD
Mirtazapine—ADRA2A—Signaling Pathways—MTOR—lung cancer	4.35e-06	2.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	4.35e-06	2.34e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	4.35e-06	2.34e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—JUN—lung cancer	4.34e-06	2.34e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—lung cancer	4.32e-06	2.33e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—lung cancer	4.31e-06	2.32e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—lung cancer	4.3e-06	2.32e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—lung cancer	4.3e-06	2.32e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SRC—lung cancer	4.29e-06	2.31e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—EP300—lung cancer	4.29e-06	2.31e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—lung cancer	4.28e-06	2.31e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—lung cancer	4.28e-06	2.31e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—lung cancer	4.28e-06	2.31e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—lung cancer	4.28e-06	2.31e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MAPK3—lung cancer	4.27e-06	2.3e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—JUN—lung cancer	4.27e-06	2.3e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—lung cancer	4.27e-06	2.3e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NRAS—lung cancer	4.27e-06	2.3e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—JUN—lung cancer	4.26e-06	2.3e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—lung cancer	4.25e-06	2.29e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NRAS—lung cancer	4.24e-06	2.29e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTP1—lung cancer	4.24e-06	2.28e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—lung cancer	4.22e-06	2.28e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—lung cancer	4.22e-06	2.27e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—lung cancer	4.21e-06	2.27e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—lung cancer	4.21e-06	2.27e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—POMC—lung cancer	4.21e-06	2.27e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CDKN1A—lung cancer	4.21e-06	2.27e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—lung cancer	4.2e-06	2.26e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—lung cancer	4.19e-06	2.26e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—JUN—lung cancer	4.18e-06	2.25e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	4.18e-06	2.25e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—lung cancer	4.18e-06	2.25e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MAPK3—lung cancer	4.18e-06	2.25e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—POMC—lung cancer	4.17e-06	2.25e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—lung cancer	4.16e-06	2.24e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—lung cancer	4.16e-06	2.24e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—lung cancer	4.15e-06	2.24e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	4.15e-06	2.24e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—lung cancer	4.15e-06	2.23e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CDKN1A—lung cancer	4.14e-06	2.23e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—lung cancer	4.14e-06	2.23e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CDKN1A—lung cancer	4.13e-06	2.23e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—lung cancer	4.13e-06	2.23e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CB—lung cancer	4.13e-06	2.23e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NRAS—lung cancer	4.13e-06	2.23e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CAT—lung cancer	4.12e-06	2.22e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—lung cancer	4.12e-06	2.22e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOA1—lung cancer	4.1e-06	2.21e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CREBBP—lung cancer	4.1e-06	2.21e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—lung cancer	4.1e-06	2.21e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—lung cancer	4.09e-06	2.21e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—lung cancer	4.09e-06	2.21e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MAPK3—lung cancer	4.09e-06	2.2e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—lung cancer	4.07e-06	2.19e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CREBBP—lung cancer	4.07e-06	2.19e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK3—lung cancer	4.06e-06	2.19e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—lung cancer	4.06e-06	2.19e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—lung cancer	4.06e-06	2.19e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	4.05e-06	2.19e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—lung cancer	4.05e-06	2.18e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	4.04e-06	2.18e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—lung cancer	4.03e-06	2.17e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—lung cancer	4.03e-06	2.17e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—lung cancer	4.03e-06	2.17e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—lung cancer	4.02e-06	2.17e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—lung cancer	4.02e-06	2.17e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ABCB1—lung cancer	4.01e-06	2.16e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EP300—lung cancer	4e-06	2.16e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—lung cancer	4e-06	2.16e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—lung cancer	3.99e-06	2.15e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—lung cancer	3.98e-06	2.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—lung cancer	3.97e-06	2.14e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—lung cancer	3.97e-06	2.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK3—lung cancer	3.95e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—lung cancer	3.95e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	3.95e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—TYMS—lung cancer	3.94e-06	2.12e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EP300—lung cancer	3.94e-06	2.12e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EP300—lung cancer	3.93e-06	2.12e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.93e-06	2.12e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—lung cancer	3.9e-06	2.1e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTM1—lung cancer	3.89e-06	2.1e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—lung cancer	3.89e-06	2.1e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SRC—lung cancer	3.89e-06	2.1e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CD—lung cancer	3.89e-06	2.1e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—lung cancer	3.89e-06	2.1e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—JUN—lung cancer	3.89e-06	2.09e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—lung cancer	3.87e-06	2.09e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—lung cancer	3.87e-06	2.08e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—lung cancer	3.86e-06	2.08e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EP300—lung cancer	3.86e-06	2.08e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CD—lung cancer	3.86e-06	2.08e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—lung cancer	3.85e-06	2.07e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—lung cancer	3.85e-06	2.07e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—lung cancer	3.84e-06	2.07e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—lung cancer	3.84e-06	2.07e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SRC—lung cancer	3.83e-06	2.06e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SRC—lung cancer	3.82e-06	2.06e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—lung cancer	3.81e-06	2.05e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—lung cancer	3.79e-06	2.04e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—lung cancer	3.78e-06	2.04e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—lung cancer	3.78e-06	2.04e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	3.77e-06	2.03e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—lung cancer	3.76e-06	2.03e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—lung cancer	3.76e-06	2.03e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—lung cancer	3.76e-06	2.02e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—lung cancer	3.75e-06	2.02e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SRC—lung cancer	3.75e-06	2.02e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CG—lung cancer	3.75e-06	2.02e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NRAS—lung cancer	3.75e-06	2.02e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—lung cancer	3.74e-06	2.02e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—lung cancer	3.73e-06	2.01e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—lung cancer	3.72e-06	2.01e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—lung cancer	3.72e-06	2e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—lung cancer	3.69e-06	1.99e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CYP1A1—lung cancer	3.69e-06	1.99e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—lung cancer	3.69e-06	1.99e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NRAS—lung cancer	3.69e-06	1.99e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—lung cancer	3.68e-06	1.99e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NRAS—lung cancer	3.68e-06	1.98e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—lung cancer	3.67e-06	1.98e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	3.67e-06	1.98e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ERCC2—lung cancer	3.66e-06	1.97e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	3.65e-06	1.97e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—lung cancer	3.65e-06	1.97e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—lung cancer	3.62e-06	1.95e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NRAS—lung cancer	3.61e-06	1.95e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK3—lung cancer	3.59e-06	1.93e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EP300—lung cancer	3.58e-06	1.93e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—lung cancer	3.58e-06	1.93e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—lung cancer	3.57e-06	1.92e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—POMC—lung cancer	3.57e-06	1.92e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—lung cancer	3.56e-06	1.92e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—lung cancer	3.55e-06	1.92e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK3—lung cancer	3.53e-06	1.9e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—lung cancer	3.53e-06	1.9e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK3—lung cancer	3.52e-06	1.9e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—lung cancer	3.49e-06	1.88e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SRC—lung cancer	3.49e-06	1.88e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CREBBP—lung cancer	3.47e-06	1.87e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	3.46e-06	1.86e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—lung cancer	3.45e-06	1.86e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—lung cancer	3.43e-06	1.85e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—lung cancer	3.43e-06	1.85e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—lung cancer	3.43e-06	1.85e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—lung cancer	3.41e-06	1.84e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—lung cancer	3.41e-06	1.84e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—EP300—lung cancer	3.4e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—lung cancer	3.4e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	3.39e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CB—lung cancer	3.39e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	3.37e-06	1.82e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—lung cancer	3.36e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—lung cancer	3.36e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CB—lung cancer	3.36e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—lung cancer	3.36e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—lung cancer	3.36e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	3.36e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NRAS—lung cancer	3.35e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—lung cancer	3.35e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—lung cancer	3.34e-06	1.8e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—lung cancer	3.33e-06	1.79e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CD—lung cancer	3.29e-06	1.78e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—lung cancer	3.29e-06	1.77e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	3.26e-06	1.76e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—lung cancer	3.26e-06	1.76e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—lung cancer	3.26e-06	1.76e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—lung cancer	3.25e-06	1.75e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—lung cancer	3.25e-06	1.75e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—lung cancer	3.22e-06	1.74e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	3.21e-06	1.73e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—lung cancer	3.19e-06	1.72e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—lung cancer	3.19e-06	1.72e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—lung cancer	3.17e-06	1.71e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—lung cancer	3.17e-06	1.71e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOA1—lung cancer	3.17e-06	1.71e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—lung cancer	3.17e-06	1.71e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—lung cancer	3.16e-06	1.7e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—lung cancer	3.16e-06	1.7e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—lung cancer	3.12e-06	1.68e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—lung cancer	3.12e-06	1.68e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—lung cancer	3.12e-06	1.68e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—lung cancer	3.11e-06	1.67e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—lung cancer	3.11e-06	1.67e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—lung cancer	3.06e-06	1.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—lung cancer	3.06e-06	1.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—lung cancer	3.02e-06	1.63e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—lung cancer	2.99e-06	1.61e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—lung cancer	2.97e-06	1.6e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—lung cancer	2.96e-06	1.6e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—lung cancer	2.93e-06	1.58e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	2.91e-06	1.57e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—lung cancer	2.91e-06	1.57e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—lung cancer	2.9e-06	1.57e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CG—lung cancer	2.89e-06	1.56e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—lung cancer	2.89e-06	1.56e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—lung cancer	2.89e-06	1.56e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—lung cancer	2.88e-06	1.55e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CB—lung cancer	2.87e-06	1.55e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—lung cancer	2.87e-06	1.54e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	2.85e-06	1.54e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—lung cancer	2.85e-06	1.53e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—lung cancer	2.82e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—lung cancer	2.82e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—lung cancer	2.81e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—EP300—lung cancer	2.79e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—EP300—lung cancer	2.77e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—lung cancer	2.76e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—lung cancer	2.76e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—POMC—lung cancer	2.75e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—lung cancer	2.74e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—lung cancer	2.74e-06	1.48e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—lung cancer	2.7e-06	1.45e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—lung cancer	2.69e-06	1.45e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CREBBP—lung cancer	2.68e-06	1.45e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—lung cancer	2.67e-06	1.44e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	2.65e-06	1.43e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—lung cancer	2.64e-06	1.42e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—lung cancer	2.62e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—lung cancer	2.59e-06	1.4e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—lung cancer	2.58e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—lung cancer	2.58e-06	1.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—lung cancer	2.57e-06	1.38e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CD—lung cancer	2.54e-06	1.37e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—lung cancer	2.53e-06	1.36e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—lung cancer	2.52e-06	1.36e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—lung cancer	2.51e-06	1.35e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—lung cancer	2.48e-06	1.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—lung cancer	2.45e-06	1.32e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—lung cancer	2.42e-06	1.3e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—lung cancer	2.38e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—lung cancer	2.38e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—EP300—lung cancer	2.37e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—lung cancer	2.35e-06	1.27e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—lung cancer	2.33e-06	1.26e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.22e-06	1.19e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—lung cancer	2.2e-06	1.18e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—lung cancer	2.17e-06	1.17e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—lung cancer	2.07e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—lung cancer	2.06e-06	1.11e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—lung cancer	2.05e-06	1.1e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—lung cancer	1.91e-06	1.03e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—EP300—lung cancer	1.83e-06	9.84e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—lung cancer	1.75e-06	9.43e-06	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—lung cancer	1.69e-06	9.1e-06	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—lung cancer	1.67e-06	9.02e-06	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—lung cancer	1.43e-06	7.71e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.35e-06	7.28e-06	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—lung cancer	1.1e-06	5.95e-06	CbGpPWpGaD
